Macquarie Group’s Sangamo Therapeutics SGMO Stock Holding History

Macquarie Group’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$217K	Hold	400,000	–	–	﹤0.01%	1532
2025 Q1	$262K	Hold	400,000	–	–	﹤0.01%	1525
2024 Q4	$408K	Hold	400,000	–	–	﹤0.01%	1462
2024 Q3	$346K	Sell	400,000 -7,669	-2%	-$6.63K	﹤0.01%	1515
2024 Q2	$146K	Buy	407,669 +7,669	+2%	+$2.74K	﹤0.01%	1572
2024 Q1	$268K	Hold	400,000	–	–	﹤0.01%	1501
2023 Q4	$217K	Hold	400,000	–	–	﹤0.01%	1537
2023 Q3	$240K	Hold	400,000	–	–	﹤0.01%	1509
2023 Q2	$520K	Hold	400,000	–	–	﹤0.01%	1451
2023 Q1	$704K	Hold	400,000	–	–	﹤0.01%	1421
2022 Q4	$1.26M	Sell	400,000 -260	-0.1%	-$816	﹤0.01%	1357
2022 Q3	$1.97M	Sell	400,260 -1,875	-0.5%	-$9.23K	﹤0.01%	1234
2022 Q2	$1.67M	Hold	402,135	–	–	﹤0.01%	1356
2022 Q1	$2.34K	Hold	402,135	–	–	﹤0.01%	1326
2021 Q4	$3.02M	Hold	402,135	–	–	﹤0.01%	1258
2021 Q3	$3.62M	Hold	402,135	–	–	﹤0.01%	1195
2021 Q2	$4.81M	Sell	402,135 -976	-0.2%	-$11.7K	﹤0.01%	1140
2021 Q1	$5.05M	Buy	403,111 +1,830	+0.5%	+$22.9K	0.01%	905
2020 Q4	$6.26M	Hold	401,281	–	–	0.01%	829
2020 Q3	$3.79M	Sell	401,281 -3,237	-0.8%	-$30.6K	0.01%	890
2020 Q2	$3.62M	Buy	404,518 +4,518	+1%	+$40.5K	0.01%	860
2020 Q1	$2.55M	Hold	400,000	–	–	0.01%	863
2019 Q4	$3.35M	Hold	400,000	–	–	﹤0.01%	901
2019 Q3	$3.62M	Hold	400,000	–	–	0.01%	842
2019 Q2	$4.31M	Buy	400,000 +285,000	+248%	+$3.07M	0.01%	813
2019 Q1	$1.1M	Buy	115,000 +61,148	+114%	+$583K	﹤0.01%	1163
2018 Q4	$618K	Buy	53,852 +1,400	+3%	+$16.1K	﹤0.01%	1255
2018 Q3	$889K	Sell	52,452 -3,310	-6%	-$56.1K	﹤0.01%	1231
2018 Q2	$792K	Buy	55,762 +22,196	+66%	+$315K	﹤0.01%	1238
2018 Q1	$638K	Buy	33,566 +13,466	+67%	+$256K	﹤0.01%	1310
2017 Q4	$330K	Buy	20,100 +18,300	+1,017%	+$300K	﹤0.01%	1574
2017 Q3	$27K	Buy	+1,800	New	+$27K	﹤0.01%	2068